A Day Up For Corvus Pharmaceuticals, Inc.

Fri, Sep 17, 2021 at 05:30 PM
A Day Up For Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) rocketted at $5.32, representing a gain of 135.4%. On Thu, Sep 16, 2021, CRVS:NASDAQ touched a New 2-Week Intraday Low of $2.22. The stock got featured on our News Catalysts scanner on Thu, Sep 16, 2021 at 12:44 PM in the 'BIOTECH' category. From Thu, Sep 02, 2021, the stock recorded 44.44% Up Days and 30.00% Green Days

The stock spiked on Fri, Sep 03, 2021 at $2.84 with a volume of 72M+.

About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.